Articles
What did you get out of the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO)?

What did you get out of the 2010 Annual Meeting of the Ameri...

Following the close of the world's largest gathering of cancer experts, four expert attendees from Kantar Health summarise what they learnt at the American Society of Clinical Oncology (ASCO) 2010 meeting. This major annual event is on a scale that is hard to imagine. Comprising 28,000 members...

Articles
Differentiating novelty in the complex oncology market

Differentiating novelty in the complex oncology market

In the wake of a mass of oncology news from the ASCO conference, Maie Gall presents a case for changes in the way differentiation for novel assets is communicated in cancer. As another American Society of Clinical Oncology (ASCO) meeting closes with an incredible amount of new compounds, new products, new indications and new combinations...

Articles
PM Society “Digital Update” advises pharma on the digital revolution

PM Society “Digital Update” advises pharma on the digital re...

Helen Lawn summarises proceedings from the UK PM Society’s recent Digital Update meeting, reviewing how pharma can remain compliant to guidelines online. Janssen-Cilag generously played host to the UK Society's sold out Digital Update Hot Topic meeting...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more